AbbVie Inc.

Ownership Transactions Reported by 30 Insiders

Symbol
ABBV on NYSE
Industry
Pharmaceutical Preparations
Location
1 North Waukegan Road, North Chicago, IL

Insiders trading volume in the past year

AbbVie Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard A. Gonzalez EXECUTIVE CHAIRMAN OF BOARD, Director $88.9M -$86.5M -49.3% Sep 30, 2024
Laura J. Schumacher Vice Chairman $46.6M Feb 25, 2022
Azita Saleki Evp, Chief Operations Officer $37.4M -$9.18M -19.7% Sep 24, 2024
Michael Severino Vice Chairman $29.8M May 23, 2022
Thomas C. Freyman Director $23.2M May 3, 2024
Thomas J. Hudson Svp, Cso, Global Research $21.9M Feb 28, 2024
Robert A. Michael Pres & Chief Operating Officer $17.4M -$12.2M -41.1% Feb 28, 2024
Henry O. Gosebruch EVP, Chief Strategy Officer $15.3M May 16, 2022
Nicholas Donoghoe Evp, Chief Bus/Strat Officer $13M -$4.17M -24.3% Mar 20, 2024
Edward J. Rapp Director $12.6M Sep 30, 2024
Jeffrey R. Stewart Evp, Chief Commercial Officer $11.1M -$10.5M -48.6% Mar 18, 2024
Glenn F. Tilton Director $8.94M May 3, 2024
Robert J. Alpern Director $7.98M Sep 30, 2024
Elaine K. Sorg Svp, Us Commercial Operations $7.24M Apr 25, 2023
Roxanne S. Austin Director $6.57M May 3, 2024
Roopal Thakkar Svp, Cmo, Global Therapeutics $6.17M Feb 28, 2024
Brian L. Durkin Vp, Controller $5.13M Feb 28, 2023
Frederick H. Waddell Director $4.89M May 3, 2024
William H.L. Burnside Director $4.54M May 3, 2024
Edward M. Liddy Director $4.41M Mar 31, 2022
Carrie Strom Svp & Pres Global Allerg Aesth $4.34M May 11, 2023
Perry C. Siatis Evp, Gc And Secretary $4.04M -$4.2M -50.9% Feb 28, 2024
Scott T. Reents Evp, Chief Financial Officer $3.83M -$2.51M -39.6% Feb 23, 2024
Brett J. Hart Director $3.22M May 3, 2024
Melody B. Meyer Director $2.7M May 3, 2024
Timothy J. Richmond Evp, Chief Hr Officer $2.46M -$13.4M -84.5% Mar 1, 2024
Kevin K. Buckbee Svp, Controller $2.24M -$909K -28.9% Feb 28, 2024
Rebecca B. Roberts Director $2.21M May 3, 2024
Susan E. Quaggin Director $295K Sep 30, 2024
Jennifer L. Davis Director $233K May 3, 2024

Recent Insider Transactions by Companies or Individuals for AbbVie Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.